Bracco

Bracco, a pharmaceutical preparation manufacturer based in Italy, reported its most recent carbon emissions for 2025. In that year, its total Scope 1 emissions were approximately 66,635,000 kg CO2e, including about 4,183,000 kg CO2e from process emissions and 743,000 kg CO2e from fugitive emissions. Scope 2 market-based emissions were approximately 52,258,000 kg CO2e, with location-based Scope 2 emissions at roughly 56,353,000 kg CO2e. These Scope 2 figures include 7,000 kg CO2e from purchased heat and 40,540,000 kg CO2e from purchased steam.

For 2024, Bracco's Scope 1 emissions were approximately 64,055,000 kg CO2e, comprising about 3,297,000 kg CO2e from process emissions and 526,000 kg CO2e from fugitive emissions. Scope 2 market-based emissions for 2024 were around 33,812,000 kg CO2e, while location-based Scope 2 emissions were roughly 48,182,000 kg CO2e, including 36,000 kg CO2e from purchased heat and 20,700,000 kg CO2e from purchased steam.

In 2023, the company reported Scope 1 emissions of approximately 61,463,000 kg CO2e, with process emissions of about 3,281,000 kg CO2e and fugitive emissions of 248,000 kg CO2e. Scope 2 market-based emissions were approximately 35,410,000 kg CO2e, and location-based Scope 2 emissions were roughly 44,712,000 kg CO2e, including 58,000 kg CO2e from purchased heat and 19,704,000 kg CO2e from purchased steam.

Bracco has not disclosed Scope 3 emissions data for any reported year. The organisation has not published any specific carbon reduction targets or commitments, such as those validated by the Science Based Targets initiative (SBTi), nor has it joined The Climate Pledge.